AM

Aditi Mahajan

Director Director DIN 09087648
DIN 09087648 First appointment Mar 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2021
Shareholding value Locked Premium profile

About Aditi Mahajan

Aditi Mahajan has 5 years in corporate governance. Formerly with 1 company, such as Capsutab Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09087648
Primary Designation Director
First Appointment 02 Mar 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Capsutab Drugs Private Limited U24230HR2021PTC093288
Director 02 Mar 2021 2021 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Capsutab Drugs Private Limited
Premium access

Shareholding and investment profile for Aditi Mahajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aditi Mahajan

Aditi Mahajan has 5 years in corporate governance. Formerly with 1 company, such as Capsutab Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Aditi Mahajan is associated with 0 companies as a director.

Aditi Mahajan has expertise in General Business.

Aditi Mahajan has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available